Neoadjuvant GW572016 to Treat Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: GW572016|DRUG: lapatinib
Sponsor: Baylor Breast Care Center
Collaborators: GlaxoSmithKline